PharmiWeb

Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® for Non-Muscle Invasive Bladder Cancer with Carcinoma In-Situ

Approval of ANKTIVA was granted for BCG-unresponsive non-muscle-invasive bladder cancer (NMIBC) with carcinoma in situ, with ...

Saudi FDA Grants Accelerated Approval to ImmunityBio’s ANKTIVA® In Combination with Checkpoint Inhibitors for Metastatic Non-Small Cell Lung Cancer

ImmunityBio, Inc. (NASDAQ: IBRX), a commercial-stage immunotherapy company, today announced that the Saudi Food and Drug ...
University of California, San Francisco

Tissue Repair Slows in Old Age. These Proteins Speed It Back Up

UCSF scientists engineered old fibroblast cells to turn their genes on and off in the same way as young fibroblasts. The old ...
Nature

Cancer might evade immune defences by stealing mitochondria

Hijacking the energy-producing organelles from immune cells seems to help tumours in mice to infiltrate lymph nodes.
eLife

Fish CDK2 recruits Dtx4 to degrade TBK1 through ubiquitination in the antiviral response

CDK2-mediated TBK1 degradation via Dtx4 represents a previously unrecognized regulatory mechanism that modulates antiviral ...